These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Platelet-activating factor antagonists treatment protects against postischemic acute renal failure in rats. López-Farré A; Bernabeu F; Gómez-Garre D; Ramon y Cajal S; Braquet P; López-Novoa JM J Pharmacol Exp Ther; 1990 Apr; 253(1):328-33. PubMed ID: 2329516 [TBL] [Abstract][Full Text] [Related]
3. Role of platelet activating factor in endotoxemic acute renal failure in the male rat. Tolins JP; Vercellotti GM; Wilkowske M; Ha B; Jacob HS; Raij L J Lab Clin Med; 1989 Mar; 113(3):316-24. PubMed ID: 2538527 [TBL] [Abstract][Full Text] [Related]
4. Ginkgolide BN 52021 protects against hemorrhagic shock-induced renal injury in rats. Kirejczyk JK; Chyczewski L; Debek W Rocz Akad Med Bialymst; 1995; 40(1):65-76. PubMed ID: 8528996 [TBL] [Abstract][Full Text] [Related]
5. Involvement of platelet-activating factor in gentamicin nephrotoxicity in rats. Rodriguez-Barbero A; López-Novoa JM; Arévalo M Exp Nephrol; 1997; 5(1):47-54. PubMed ID: 9052848 [TBL] [Abstract][Full Text] [Related]
6. Prevention of cyclosporin nephrotoxicity with a platelet-activating factor (PAF) antagonist. Bagnis C; Deray G; Dubois M; Pirotzky E; Jacquiaud C; Baghos W; Aupetit B; Braquet P; Jacobs C Nephrol Dial Transplant; 1996 Mar; 11(3):507-13. PubMed ID: 8671822 [TBL] [Abstract][Full Text] [Related]
7. Neutrophils accentuate renal cold ischemia-reperfusion injury. Dose-dependent protective effect of a platelet-activating factor receptor antagonist. Riera M; Torras J; Herrero I; Valles J; Paubert-Braquet M; Cruzado JM; Alsina J; Grinyo JM J Pharmacol Exp Ther; 1997 Feb; 280(2):786-94. PubMed ID: 9023292 [TBL] [Abstract][Full Text] [Related]
9. Role of platelet activating factor in gentamicin and cisplatin nephrotoxicity. Dos Santos OF; Boim MA; Barros EJ; Schor N Kidney Int; 1991 Oct; 40(4):742-7. PubMed ID: 1745025 [TBL] [Abstract][Full Text] [Related]
10. Platelet-activating factor antagonist, BN-52021 protects against cis-diamminedichloroplatinum nephrotoxicity in the rat. Pirotzky E; Guilmard C; Sidoti C; Ivanow F; Principe P; Braquet P Ren Fail; 1990; 12(3):171-6. PubMed ID: 2287769 [TBL] [Abstract][Full Text] [Related]
11. Hemodynamic effects of PAF-acether on the dog kidney. Hébert RL; Sirois P; Braquet P; Plante GE Prostaglandins Leukot Med; 1987 Mar; 26(3):189-202. PubMed ID: 3033688 [TBL] [Abstract][Full Text] [Related]
12. Effect of platelet-activating factor and its specific receptor antagonist on glomerular permeability to proteins in isolated perfused rat kidney. Perico N; Delaini F; Tagliaferri M; Abbate M; Cucchi M; Bertani T; Remuzzi G Lab Invest; 1988 Feb; 58(2):163-71. PubMed ID: 3123798 [TBL] [Abstract][Full Text] [Related]
13. Effect of a platelet-activating factor (PAF) receptor antagonist on hyperacute xenograft rejection; evaluation in a pig kidney-human blood xenoperfusion model. Cruzado JM; Torras J; Riera M; Lloberas N; Herrero I; Condom E; Martorell J; Alsina J; Grinyó JM Clin Exp Immunol; 1998 Jul; 113(1):136-44. PubMed ID: 9697996 [TBL] [Abstract][Full Text] [Related]
14. Effects of intrastriatal injections of platelet-activating factor and the PAF antagonist BN 52021 on memory. Packard MG; Teather LA; Bazan NG Neurobiol Learn Mem; 1996 Sep; 66(2):176-82. PubMed ID: 8946410 [TBL] [Abstract][Full Text] [Related]
15. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds. Baroggi N; Etienne A; Braquet P Agents Actions Suppl; 1986; 20():87-97. PubMed ID: 3028108 [TBL] [Abstract][Full Text] [Related]
16. Effect of platelet-activating factor antagonist on cyclosporine nephrotoxicity. Glomerular hemodynamics evaluation. dos Santos OF; Boim MA; Bregman R; Draibe SA; Barros EJ; Pirotzky E; Schor N; Braquet P Transplantation; 1989 Apr; 47(4):592-5. PubMed ID: 2705209 [TBL] [Abstract][Full Text] [Related]
17. Effect of long-term treatment with platelet-activating factor on IL-1 and IL-2 production by rat spleen cells. Pignol B; Hénane S; Sorlin B; Rola-Pleszczynski M; Mencia-Huerta JM; Braquet P J Immunol; 1990 Aug; 145(3):980-4. PubMed ID: 2373865 [TBL] [Abstract][Full Text] [Related]